News | July 06, 2010

$10.6 Million Center Established to Study New MRI Technology

July 6, 2010 – The development of a new magnetic resonance imaging (MRI) technology, which may revolutionize the way medical conditions are diagnosed and treated, is to take a major step forward as a $10.6 million research center is established at the University of York.

Hyperpolarization with parahydrogen is a technique developed at the university that can dramatically increase the sensitivity of MRIs. It is hoped hyperpolarization will eventually be used to help doctors make diagnoses in minutes that currently take days and tailor treatments more accurately to the needs of individual patients.

The research team, led by professors Simon Duckett and Gary Green, of the departments of chemistry and psychology respectively, has secured a grant from the Wellcome Trust and Wolfson Foundation, as well as financial support from industrial partners and the university, to build the York Centre for Hyperpolarisation in Magnetic Resonance Imaging.

“Although MRI is already an incredibly useful technique, its sensitivity is in fact very low, rather like finding a needle in a haystack, which makes it difficult to detect the early stages of disease. It can also be very slow, limiting the way MRI is used in clinical settings,” Duckett said.

The York Centre will bring together researchers from across the departments of chemistry, psychology, biology and the Hull York Medical School to develop this technology. The team will also be working with professor Jürgen Hennig of the University Hospital Freiburg, one of the world’s leading experts in the medical application of MRI technology.

Hyperpolarization involves transferring the magnetism of parahydrogen to molecules, making them more visible to nuclear magnetic resonance, an important research tool in chemistry, and magnetic resonance imaging. The new center’s early research program will develop the chemical basis of this method to make it suitable for medical applications.

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.